• $841,405.00
    Market Cap
  • -47.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
03/31/2025
03/31/2024
03/31/2023
03/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
0
N/A
0
-100.00%
Cost of Revenue
N/A
N/A
N/A
N/A
0
N/A
0
-100.00%
Gross Profit
0
N/A
0
N/A
0
N/A
0
-100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-180,987
+3.26%
-175,268
-75.37%
-711,506
+404.61%
-141,000
-61.38%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
513,251
-31.09%
744,810
-45.70%
1.4M
-40.13%
2.3M
+70.86%
Operating Profit
-513,251
-31.09%
-744,810
-45.70%
-1.4M
-40.13%
-2.3M
+70.86%
Interest Income
0
-100.00%
248
N/A
N/A
N/A
0
+100.00%
Interest Expense
-42,669
+102.86%
-21,034
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-42,669
+105.28%
-20,786
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
-53,797
-66.30%
-159,656
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-567,048
-3.09%
-585,154
-57.41%
-1.4M
-40.04%
-2.3M
+70.95%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-567,048
-3.09%
-585,154
-57.41%
-1.4M
-40.04%
-2.3M
+70.95%
Net Income from Continuing Operations Applicable to Common
-567,048
-3.09%
-585,154
-57.41%
-1.4M
-40.04%
-2.3M
+70.95%
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
-0.01
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
40.1M
0.00%
40.1M
+2.13%
39.2M
N/A
N/A
N/A
Diluted Weighted Average Shares
40.1M
0.00%
40.1M
+2.13%
39.2M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
4,477
-31.49%
6,535
-47.17%
12,369
+8,430.34%
145
-91.80%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
4,477
-31.49%
6,535
-47.17%
12,369
+8,430.34%
145
-91.80%
Total Current Assets
100,274
-5.73%
106,372
-59.31%
261,392
+1,535.95%
15,978
-68.80%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
100,274
-5.73%
106,372
-59.31%
261,392
+1,535.95%
15,978
-68.80%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
5,000
N/A
Total Current Liabilities
3.2M
+20.17%
2.7M
+6.22%
2.5M
+129.70%
1.1M
+80.08%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
N/A
0
N/A
0
N/A
0
N/A
Total Liabilities
3.2M
+20.17%
2.7M
+6.22%
2.5M
+129.70%
1.1M
+80.08%
Retained Earnings
-6.5M
+9.52%
-6.0M
+10.90%
-5.4M
+34.38%
-4.0M
+134.44%
Total Stockholders Equity
-3.1M
+21.25%
-2.6M
+13.83%
-2.2M
+108.84%
-1.1M
+93.80%
Total Shares Outstanding
40.1M
0.00%
40.1M
0.00%
40.1M
+2.96%
38.9M
+11.59%
Cash Flow
Cash from Operating Activities
-125,078
+13.27%
-110,429
+24.72%
-88,541
+5,355.39%
-1,623
-99.61%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
100,000
+7.53%
93,000
-7.00%
100,000
N/A
0
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-548.81%
+72.46%
-318.22%
-67.88%
-990.59%
-85.48%
-6,820.76%
+775.16%
Return on Equity
20.02%
-17.72%
24.33%
-70.54%
82.61%
-70.57%
280.67%
-65.21%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
-100.00%
N/A
Current Ratio
0.03
-21.55%
0.04
-61.67%
0.10
+613.01%
0.01
-82.70%
Cash Ratio
0.001
-44.00%
0.003
-48.98%
0.005
+4,800.00%
0.0001
-96.55%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow